个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
谢忠平,男,中国共产党党员、主任技师、硕士研究生导师、“云南省技术创新人才”、云南省委组织部联系专家,获云南省政府特殊津贴,被评为北京协和医学院优秀教师,2020年被授予“全国抗击新冠肺炎疫情先进个人”称号。现任北京协和医学院、中国医学科学院医学生物学研究所副所长。1987年7月毕业于昆明医学院(昆明医科大学),自大学毕业后参加工作以来,从事疫苗质量检定及疫苗研究相关工作30余年,积累了丰富的经验。作为项目负责人主持国家863项目、国家科技支撑计划、国家重大新药创制项目、云南省重点项目等项目的研究工作。作为疫苗研发的主要成员,参加了包括“肠道病毒71型灭活疫苗(人二倍细胞)” 及“Sabin株脊髓灰质炎灭活疫苗(Vero)”两个国家一类新药的研究;在2020年突发的新型冠状病毒肺炎科技攻关活动中,参加了国务院联防联控机制科技攻关组疫苗研发工作,主持医科院创新先导研究项目。研究成果曾获云南省技术发明特等奖、云南省科技进步特等奖、云南省科技进步一等奖等省部级科技奖励共10项;获得技术发明专利5项,出版专业论著一部、发表研究论文70余篇。主要研究方向为病毒性疫苗及体外诊断试剂研究,研究团队包括正高2人、副高1人,其中博士3人、硕士1人。培养研究生全部按期毕业,学生毕业去向包括升学博士及就业。工作单位包括科研院所、省市级三甲医院、政府机关、大专院校及制药公司等。
团队简介
Team Profile
待补充更新
硕士研究生 0 名,博士研究生 0 名
无
# | 论文题目 | 期刊名称 | 发表年份 | 论文署名 |
---|---|---|---|---|
1 | Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys | Human Vaccines & Immunotherapeutics | 2023-07-11 | 谢忠平 |
2 | SARS-CoV-2 Omicron (B.1.1.529) infection in rhesus macaques, hamsters, and BALB/c mice with severe lung histopathological damage | Journal of Medical Virology | 2023-07-11 | 谢忠平 |
3 | A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine | Journal of Medical Virology | 2023-07-11 | 谢忠平 |
4 | Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern | Signal Transduction and Targeted Therapy | 2023-07-11 | 谢忠平 |
5 | Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques | Signal Transduction and Targeted Therapy | 2023-07-11 | 谢忠平 |
6 | Comparative analysis of the biological characteristics of three CV-A10 clones adaptively cultured on Vero cells | Journal of Medical Virology | 2023-07-11 | 谢忠平 |
7 | PTP1B negatively regulates nitric oxide mediated Pseudomonas aeruginosa killing by neutrophils | PLoS ONE | 2023-07-11 | 谢忠平 |
8 | CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection | PLoS ONE | 2023-07-11 | 谢忠平 |
9 | N‐terminally truncated nucleocapsid protein of SARS‐CoV‐2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS‐CoV‐2 | Journal of Medical Virology | 2023-07-11 | 谢忠平 |
10 | A comparative study on biological characteristics of ten coxsackievirus A10 virus strain | Virology | 2023-07-11 | 谢忠平 |
11 | PTP1B negatively regulates STAT1-independent Pseudomonas aeruginosa killing by macrophages | Biochemical and Biophysical Research Communications | 2023-07-11 | 谢忠平 |
12 | Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71 | Vaccine | 2023-07-11 | 谢忠平 |
13 | Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern | Emerging microbes & infections | 2023-07-11 | 谢忠平 |
14 | Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine | Biomedicine & Pharmacotherapy | 2023-07-11 | 谢忠平 |
15 | Immune responses of a CV-A16 live attenuated candidate strain and its protective effects in rhesus monkeys | Emerging microbes & infections | 2023-07-11 | 谢忠平 |
无
无